Patents by Inventor Elaine S. Krul

Elaine S. Krul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160002294
    Abstract: The present invention relates to novel polypeptides having satiety hormone releasing activity (e.g., cholecystokinin (CCK) and/or glucagon-like peptide-1 (GLP-1) releasing activity).
    Type: Application
    Filed: January 28, 2014
    Publication date: January 7, 2016
    Applicant: Solae, LLC
    Inventors: Barry M. Tulk, Elaine S. Krul, Nancy J. McGraw
  • Publication number: 20130331315
    Abstract: The present invention provides protein hydrolysate compositions having enhanced cholecystokinin (CCK) and/or giuoagon-like peptide-1 (GLP-1) releasing activity and food forms incorporating the protein hydrolysate compositions, which can be used to promote satiety.
    Type: Application
    Filed: February 23, 2012
    Publication date: December 12, 2013
    Applicant: Solae, LLC
    Inventors: Elaine S. Krul, Barry Tulk, Mary K. Pawlik, Jason F. Lombardi
  • Publication number: 20040067918
    Abstract: Novel methods and combinations for the treatment and/or prophylaxis of a pathologic condition in a subject, wherein the methods comprise the administration of one or more aldosterone receptor antagonists and one or more, nicotinic acid derivatives and the combinations comprise one or more of said aldosterone receptor antagonists and one or more of said nicotinic acid derivatives.
    Type: Application
    Filed: March 18, 2003
    Publication date: April 8, 2004
    Inventors: Bradley T. Keller, Ellen G. McMahon, Elaine S. Krul
  • Publication number: 20030162824
    Abstract: Methods for treating or preventing one or more cardiovascular conditions in a subject comprising treating the subject with a therapeutically effective amount of a selective cyclooxygenase-1 inhibitor or a pharmaceutically-acceptable salt, tautomer or prodrug thereof alone or in combination with either a drug used in the treatment or prevention of a cardiovascular condition or a non-drug therapy used in the treatment of a cardiovascular condition.
    Type: Application
    Filed: November 12, 2002
    Publication date: August 28, 2003
    Inventor: Elaine S. Krul